Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,559,493
-$463,025 QoQ
Shares Held
64,763
-10.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#1,076
of 2,821 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DoubleLine ETF Adviser LP holds $33,080,226 across 9 Drug Manufacturers - General names. PFE ranks #7 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,779 | $10,529,796 | |
| 2 | JNJ |
Johnson & Johnson
|
26,686 | $6,777,443 | |
| 3 | ABBV |
AbbVie Inc.
|
19,587 | $4,928,872 | |
| 4 | MRK |
Merck & Co., Inc.
|
27,527 | $3,537,219 | |
| 5 | AMGN |
Amgen Inc
|
6,079 | $2,201,327 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
14,087 | $1,779,751 | |
| 7 | PFE |
Pfizer Inc
This page
|
64,763 | $1,559,493 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
23,354 | $1,345,657 |
All Filings in PFE
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,559,493 | 64,763 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,022,518 | 72,027 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||